LFVN - Lifevantage Corp Stock Price, Fair Value and News

6.79USD-0.41 (-5.69%)Market Closed

Market Summary

USD6.79-0.41

Market Closed

-5.69%

LFVN Stock Price

View Fullscreen

LFVN RSI Chart

LFVN Valuation

Market Cap

86.2M

Price/Earnings (Trailing)

23.97

Price/Sales (Trailing)

0.42

EV/EBITDA

8.68

Price/Free Cashflow

7.91

LFVN Price/Sales (Trailing)

LFVN Profitability

EBT Margin

2.04%

Return on Equity

13.44%

Return on Assets

5.87%

Free Cashflow Yield

12.64%

LFVN Fundamentals

LFVN Revenue

Revenue (TTM)

205.5M

Rev. Growth (Yr)

-10.23%

Rev. Growth (Qtr)

-6.55%

LFVN Earnings

Earnings (TTM)

3.6M

Earnings Growth (Yr)

62.33%

Earnings Growth (Qtr)

352.9%

Breaking Down LFVN Revenue

Last 7 days

1.3%

Last 30 days

2.9%

Last 90 days

-0.9%

Trailing 12 Months

61.8%

How does LFVN drawdown profile look like?

LFVN Financial Health

Current Ratio

1.68

LFVN Investor Care

Buy Backs (1Y)

0.74%

Diluted EPS (TTM)

0.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	205.5M	0	0	0
2023	210.1M	213.4M	213.0M	210.9M
2022	210.2M	206.4M	204.9M	206.4M
2021	224.8M	220.2M	218.6M	211.8M
2020	229.7M	232.9M	231.5M	229.3M
2019	223.8M	226.0M	226.6M	229.7M
2018	199.8M	203.2M	209.7M	218.4M
2017	201.9M	199.5M	193.7M	194.3M
2016	198.8M	206.5M	216.1M	213.0M
2015	201.1M	190.3M	184.1M	187.8M
2014	209.4M	214.0M	214.3M	211.0M
2013	201.3M	208.2M	206.6M	204.7M
2012	96.6M	126.2M	159.0M	187.1M
2011	0	38.9M	52.6M	70.4M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Lifevantage Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 28, 2024	cunningham kristen	sold (taxes)	-14,949	6.185	-2,417	chief sales officer
Apr 26, 2024	neufeld alissa	sold (taxes)	-25,983	6.185	-4,201	general counsel
Apr 01, 2024	neufeld alissa	acquired	-	-	2,668	general counsel
Apr 01, 2024	neufeld alissa	sold (taxes)	-16,895	6.39	-2,644	general counsel
Apr 01, 2024	aure carl	sold (taxes)	-12,709	6.39	-1,989	chief financial officer
Apr 01, 2024	cunningham kristen	acquired	-	-	3,001	chief sales officer
Apr 01, 2024	fife steven r	acquired	-	-	20,234	president and ceo
Apr 01, 2024	fife steven r	sold (taxes)	-96,533	6.39	-15,107	president and ceo
Apr 01, 2024	aure carl	acquired	-	-	2,401	chief financial officer
Apr 01, 2024	boyster julie	sold (taxes)	-14,083	6.39	-2,204	chief marketing officer

Which funds bought or sold LFVN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 17, 2024	Kozak & Associates, Inc.	new	-	180	180	-%
May 16, 2024	Beacon Capital Management, LLC	unchanged	-	-70.00	1,059	-%
May 15, 2024	STATE STREET CORP	reduced	-6.44	-15,820	263,726	-%
May 15, 2024	CITADEL ADVISORS LLC	sold off	-100	-6,162	-	-%
May 15, 2024	Royal Bank of Canada	added	89.27	10,000	22,000	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-95.64	-3,425	157	-%
May 15, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	added	5.96	39,557	617,723	0.01%
May 15, 2024	Steward Partners Investment Advisory, LLC	sold off	-100	-5,790	-	-%
May 15, 2024	BARCLAYS PLC	unchanged	-	2,000	184,000	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	sold off	-100	-36.00	-	-%

Are Funds Buying or Selling LFVN?

Are funds buying LFVN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LFVN

No. of Funds

Unveiling Lifevantage Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 15, 2024	sudbury capital management, llc	5.8%	749,325	SC 13D/A
Feb 15, 2024	radoff bradley louis	6.7%	50,000	SC 13D/A
Feb 13, 2024	renaissance technologies llc	6.51%	838,118	SC 13G/A
Nov 14, 2023	sudbury capital management, llc	5.9%	749,325	SC 13D/A
Nov 14, 2023	radoff bradley louis	6.8%	50,000	SC 13D/A
Aug 11, 2023	sudbury capital fund, lp	5.7%	732,821	SC 13D/A
Aug 11, 2023	radoff bradley louis	6.6%	30,000	SC 13D/A
May 15, 2023	radoff bradley louis	5.7%	25,728	SC 13D
Feb 13, 2023	renaissance technologies llc	6.76%	858,718	SC 13G/A
Feb 09, 2023	vanguard group inc	3.69%	463,326	SC 13G/A

Recent SEC filings of Lifevantage Corp

View All Filings

Date Filed	Form Type	Document
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 30, 2024	4	Insider Trading
Apr 30, 2024	4	Insider Trading
Apr 16, 2024	8-K	Current Report
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading

Peers (Alternatives to Lifevantage Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ADM	30.5B	91.7B	1.99%	-15.35%	10.02	0.33	-10.07%	-31.73%
BG	15.0B	61.3B	-2.21%	16.07%	7.7	0.25	-8.91%	30.43%
CAG	14.7B	12.1B	1.62%	-14.16%	15.43	1.21	-0.78%	18.26%
CPB	13.8B	9.3B	7.27%	-12.09%	18.08	1.49	1.02%	-5.78%
ACI	11.9B	79.2B	0.88%	1.68%	9.19	0.15	2.05%	-14.37%
MID-CAP
BRBR	7.5B	1.8B	5.71%	59.23%	39.11	4.06	23.06%	29.48%
FRPT	6.1B	823.2M	20.41%	92.18%	627.36	7.45	30.53%	114.65%
FLO	5.2B	5.1B	4.80%	-15.22%	41.05	1.01	4.66%	-41.11%
CENT	3.0B	3.3B	17.04%	57.25%	20.35	0.91	1.49%	31.18%
CALM	2.8B	2.4B	-3.61%	21.31%	10.29	1.19	-22.17%	-63.60%
SMALL-CAP
ANDE	1.8B	13.6B	-9.19%	34.04%	14.42	0.13	-21.14%	9.65%
BGS	743.1M	2.0B	-11.49%	-26.60%	-6.76	0.37	-5.45%	-247.51%
BYND	467.2M	326.7M	11.98%	-36.95%	-1.4	1.43	-18.66%	-2.70%
ALCO	208.0M	103.1M	2.36%	17.74%	5.21	2.02	56.46%	236.17%
AQB	7.1M	2.6M	5.71%	277.55%	-0.22	2.8	-0.77%	-36.97%

Lifevantage Corp News

Latest updates

Lifevantage Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-6.5%	48,245	51,624	51,364	54,221	53,741	53,662	51,774	50,943	50,004	52,189	53,224	54,777	51,570	59,007	54,827	59,368	56,077	61,242	56,228	56,170	56,012
Gross Profit	-6.1%	38,073	40,558	41,184	43,152	43,123	41,904	41,832	41,611	40,347	42,512	43,793	44,995	42,752	48,818	45,429	49,919	46,982	51,012	47,038	46,460	46,742
Operating Expenses	-13.6%	36,139	41,819	40,435	40,550	41,524	43,136	40,542	40,115	38,522	42,870	39,181	38,414	40,664	43,369	41,932	43,710	43,949	47,366	44,460	40,792	44,501
S&GA Expenses	-18.1%	16,425	20,065	17,962	17,048	17,708	19,580	16,729	15,612	15,316	17,421	15,076	12,811	15,510	16,218	16,299	14,816	17,281	18,131	17,686	15,338	17,296
R&D Expenses	-	200	-	-	-	200	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	6.7%	0.04*	0.04*	0.04*	0.03*	0.02*	0.02*	0.02*	0.04*	0.07*	0.07*	0.10*	0.09*	-	-	-	-	-	-	-	-	-
Interest Expenses	-29.6%	76.00	108	168	-289	59.00	32.00	-	17.00	-5.00	-1.00	3.00	-	2.00	9.00	6.00	1.00	30.00	41.00	48.00	41.00	72.00
Income Taxes	157.5%	262	-456	200	612	643	-17.00	200	422	610	-577	1,116	1,571	107	1,761	899	2,259	1,005	-846	700	1,573	376
Earnings Before Taxes	272.8%	1,921	-1,112	829	2,557	1,665	-1,075	852	-994	1,751	-498	4,432	6,478	1,831	5,573	3,350	6,088	2,666	3,457	2,450	5,498	2,158
EBT Margin	9.4%	0.02*	0.02*	0.02*	0.02*	0.00*	0.00*	0.01*	0.02*	0.06*	0.06*	0.08*	0.08*	-	-	-	-	-	-	-	-	-
Net Income	352.9%	1,659	-656	629	1,966	1,022	-1,058	610	-1,416	1,141	79.00	3,316	4,907	1,724	3,812	2,451	3,824	1,661	4,303	1,761	3,907	1,782
Net Income Margin	24.8%	0.02*	0.01*	0.01*	0.01*	0.00*	0.00*	0.00*	0.02*	0.04*	0.05*	0.06*	0.06*	-	-	-	-	-	-	-	-	-
Free Cashflow	130.8%	2,802	1,214	3,632	3,250	2,453	130	-2,072	2,514	306	3,522	87.00	7,894	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-2.2%	61.00	63.00	67.00	66.00	67.00	68.00	68.00	71.00	72.00	72.00	76.00	79.00	75.00	74.00	70.00	59.00	52.00	55.00	56.00	55.00	54.00
Current Assets	-2.2%	38.00	39.00	42.00	44.00	44.00	44.00	43.00	47.00	45.00	43.00	45.00	48.00	44.00	42.00	41.00	44.00	38.00	38.00	42.00	43.00	43.00
Cash Equivalents	0.3%	17.00	17.00	18.00	22.00	20.00	17.00	18.00	20.00	18.00	20.00	20.00	23.00	19.00	20.00	18.00	22.00	13.00	14.00	13.00	19.00	16.00
Inventory	1.3%	15.00	15.00	16.00	16.00	18.00	20.00	19.00	16.00	16.00	15.00	16.00	16.00	15.00	15.00	15.00	14.00	15.00	14.00	15.00	14.00	14.00
Net PPE	-6.9%	8.00	9.00	9.00	9.00	9.00	9.00	9.00	10.00	10.00	10.00	11.00	11.00	11.00	11.00	7.00	7.00	7.00	8.00	7.00	7.00	7.00
Liabilities	-2.4%	35.00	35.00	37.00	31.00	34.00	36.00	36.00	39.00	38.00	37.00	38.00	42.00	39.00	39.00	36.00	26.00	24.00	26.00	26.00	28.00	29.00
Current Liabilities	-2.4%	22.00	23.00	25.00	20.00	21.00	23.00	23.00	26.00	24.00	22.00	22.00	25.00	22.00	22.00	22.00	25.00	23.00	25.00	25.00	26.00	27.00
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	1.00	1.00	2.00
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-2.0%	27.00	27.00	29.00	35.00	33.00	32.00	32.00	32.00	34.00	35.00	37.00	37.00	36.00	36.00	34.00	33.00	29.00	29.00	30.00	27.00	25.00
Retained Earnings	-0.7%	-107	-106	-104	-98.30	-99.00	-99.64	-98.20	-98.44	-96.18	-95.60	-92.52	-92.35	-93.32	-93.04	-92.86	-93.31	-97.13	-96.79	-99.08	-99.96	-100
Additional Paid-In Capital	0.5%	136	135	135	134	133	133	132	131	131	131	130	129	129	128	127	126	126	126	129	127	126
Shares Outstanding	-1.5%	13.00	13.00	13.00	13.00	13.00	13.00	12.00	12.00	13.00	13.00	13.00	14.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	44.00	-	-	-	81.00	-	-	-	132	-	-	-	223	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	76.0%	3,093	1,757	4,765	3,763	3,443	967	-1,345	2,780	671	4,043	465	8,374	3,059	5,893	-1,053	9,349	3,212	9,225	-3,460	6,984	3,863
Share Based Compensation	6.1%	796	750	978	946	817	823	602	406	-38.00	755	645	-79.00	668	983	464	838	1,163	1,546	1,372	1,389	1,083
Cashflow From Investing	46.4%	-291	-543	-1,133	-505	-990	-837	-727	-266	-365	-521	-378	-473	-1,729	-572	-960	-574	-474	-881	-752	-817	-1,417
Cashflow From Financing	3.1%	-2,464	-2,544	-6,668	-1,323	-306	-400	-328	-882	-1,562	-3,185	-3,323	-3,676	-1,853	-3,675	-2,249	-148	-3,852	-6,818	-1,604	-3,313	-5,492
Dividend Payments	-100.0%	-	455	5,534	445	383	381	377	378	-	-	-	-	-	-	-	-	-	-	-	-	-
Buy Backs	1.5%	1,928	1,900	795	822	383	-	-	427	1,700	3,154	3,492	3,900	2,000	4,000	2,000	-	2,000	2,012	1,393	2,949	206

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

LFVN Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue, net	$ 48,245	$ 53,741	$ 151,233	$ 159,177
Cost of sales	10,172	10,618	31,418	32,318
Gross profit	38,073	43,123	119,815	126,859
Operating expenses:
Commissions and incentives	19,714	23,816	63,941	71,185
Selling, general and administrative	16,425	17,708	54,452	54,018
Total operating expenses	36,139	41,524	118,393	125,203
Operating income	1,934	1,599	1,422	1,656
Other income (expense):
Interest income, net	76	59	352	91
Other income (expense), net	(89)	7	(135)	(304)
Total other income (expense)	(13)	66	217	(213)
Income before income taxes	1,921	1,665	1,639	1,443
Income tax expense	(262)	(643)	(7)	(869)
Net income	$ 1,659	$ 1,022	$ 1,632	$ 574
Net income per share:
Basic (in USD per share)	$ 0.13	$ 0.08	$ 0.13	$ 0.05
Diluted (in USD per share)	$ 0.13	$ 0.08	$ 0.13	$ 0.05
Weighted-average shares outstanding:
Basic (in shares)	12,424	12,615	12,525	12,538
Diluted (in shares)	12,986	12,770	13,010	12,555
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment	$ (529)	$ 14	$ (360)	$ 144
Other comprehensive (loss) income, net of tax	(529)	14	(360)	144
Comprehensive income	$ 1,130	$ 1,036	$ 1,272	$ 718

LFVN Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Current assets
Cash and cash equivalents	$ 17,377	$ 21,605
Accounts receivable	2,135	1,612
Income tax receivable	360	241
Inventory, net	15,162	16,073
Prepaid expenses and other	2,763	4,753
Total current assets	37,797	44,284
Long-term assets
Property and equipment, net	8,349	9,086
Right-of-use assets	9,382	8,738
Intangible assets, net	356	455
Deferred income tax asset	4,927	2,991
Other long-term assets	496	569
TOTAL ASSETS	61,307	66,123
Current liabilities
Accounts payable	6,954	3,505
Commissions payable	6,093	6,651
Income tax payable	772	0
Lease liabilities	1,675	1,521
Other accrued expenses	6,981	7,932
Total current liabilities	22,475	19,609
Long-term lease liabilities	11,852	11,566
Other long-term liabilities	211	299
Total liabilities	34,538	31,474
Commitments and contingencies - Note 7
Stockholders’ equity
Preferred stock — par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding	0	0
Common stock — par value $0.0001 per share, 40,000 shares authorized and 12,688 and 12,622 issued and outstanding as of March 31, 2024 and June 30, 2023, respectively	1	1
Additional paid-in capital	136,198	134,314
Accumulated deficit	(107,709)	(98,305)
Accumulated other comprehensive loss	(1,721)	(1,361)
Total stockholders’ equity	26,769	34,649
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 61,307	$ 66,123

About Lifevantage Corp

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

CEO	Mr. Steven R. Fife
WEBSITE	lifevantage.com
INDUSTRY	Packaged Foods
EMPLOYEES	248

Lifevantage Corp Frequently Asked Questions

What is the ticker symbol for Lifevantage Corp? What does LFVN stand for in stocks?

LFVN is the stock ticker symbol of Lifevantage Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lifevantage Corp (LFVN)?

As of Fri May 17 2024, market cap of Lifevantage Corp is 86.24 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LFVN stock?

You can check LFVN's fair value in chart for subscribers.

What is the fair value of LFVN stock?

You can check LFVN's fair value in chart for subscribers. The fair value of Lifevantage Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lifevantage Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LFVN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lifevantage Corp a good stock to buy?

The fair value guage provides a quick view whether LFVN is over valued or under valued. Whether Lifevantage Corp is cheap or expensive depends on the assumptions which impact Lifevantage Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LFVN.

What is Lifevantage Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, LFVN's PE ratio (Price to Earnings) is 23.97 and Price to Sales (PS) ratio is 0.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LFVN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Lifevantage Corp's stock?

In the past 10 years, Lifevantage Corp has provided -0.026 (multiply by 100 for percentage) rate of return.